1. Home
  2. TYRA vs FLNC Comparison

TYRA vs FLNC Comparison

Compare TYRA & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$31.06

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$14.28

Market Cap

2.1B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
FLNC
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TYRA
FLNC
Price
$31.06
$14.28
Analyst Decision
Strong Buy
Hold
Analyst Count
11
17
Target Price
$47.50
$15.71
AVG Volume (30 Days)
923.4K
8.8M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,262,830,000.00
Revenue This Year
N/A
$51.23
Revenue Next Year
N/A
$21.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.96
$6.60
52 Week High
$40.65
$33.51

Technical Indicators

Market Signals
Indicator
TYRA
FLNC
Relative Strength Index (RSI) 49.81 35.74
Support Level $28.92 $12.15
Resistance Level $31.57 $16.40
Average True Range (ATR) 1.87 1.43
MACD 0.05 -0.33
Stochastic Oscillator 47.47 12.23

Price Performance

Historical Comparison
TYRA
FLNC

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

Share on Social Networks: